Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, March 11, 2019 at 4:00 PM to 4:30 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 26.04.18 in Vol 4, No 2 (2018): Apr-Jun

This paper is in the following e-collection/theme issue:

Works citing "Public Awareness of Uterine Power Morcellation Through US Food and Drug Administration Communications: Analysis of Google Trends Search Term Patterns"

According to Crossref, the following articles are citing this article (DOI 10.2196/publichealth.9913):

(note that this is only a small subset of citations)

  1. Matsushita T, Sekizawa A, Jacobs LK. Racial Disparities in Response to a US Food and Drug Administration Safety Communication Regarding the Use of Power Morcellation for the Treatment of Uterine Leiomyoma. Journal of Minimally Invasive Gynecology 2020;27(1):178
  2. Zaami S, Zupi E, Lazzeri L, Stark M, Malvasi A, Signore F, Marinelli E. Medicolegal Issues in Power Morcellation: Cautionary Rules for Gynecologists to Avoid Unfavorable Outcomes. Journal of Minimally Invasive Gynecology 2020;27(3):583
  3. Liou N, Mallick R, Aref-Adib M, Odejinmi F. Google searches and medical publication trends since the 2014 US Food and Drug Administration position on power morcellation: Do these translate into patient awareness?. European Journal of Obstetrics & Gynecology and Reproductive Biology 2019;243:168